日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial

利鲁唑联合mFOLFOX6和贝伐单抗治疗转移性结直肠癌患者：一项I期临床试验

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-3964
Li, Chunjie; Noonan, Anne M; Hays, John; Roychowdhury, Sameek; Malalur, Pannaga; Elkhatib, Rifat; Manne, Ashish; Mittra, Arjun; Rahman, Shafia; Yan, Liwei; Hill, Kasey; Abbott, Nicole; Phelps, Mitch; Na, Joo Young; Liang, Beiyuan; Storts, Hayden; Khan, Misbah; Zhang, Evan H; Miles, Wayne; Yildiz, Vedat; Wei, Lai; Wang, Jing J; Jin, Ning
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth.

髓样甲状腺癌蛋白质组学分析发现 CAPN1 是 NF1 和 RET 驱动生长的关键调节因子

期刊:Thyroid
影响因子:6.7
doi:10.1089/thy.2024.0102
Khan Eshan, Hylton Hannah, Rajan Neel, Bouley Stephanie J, Siddiqui Jalal K, Rajasekaran Swetha, Koshre Ganesh R, Storts Hayden, Valenciaga Anisley, Khan Misbah, Liyanarachchi Sandya, Fernandez Francisco, Zheng Xuguang, Phay John, Dedhia Priya H, Wang Jing, Walker James A, Ringel Matthew D, Miles Wayne O
肿瘤
甲状腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.

利鲁唑通过激活结直肠癌中的 cGAS/STING 信号通路增强抗 PD-1 疗效

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0289
Liang Beiyuan, Khan Misbah, Storts Hayden, Zhang Evan H, Zheng Xinru, Xing Xuanxuan, Claybon Hazel, Wilson Jenna, Li Chunjie, Jin Ning, Fishel Richard, Miles Wayne O, Wang Jing J
肿瘤
肠癌
发表日期：2025
文献求助 收藏